Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jung-Hyun Kim, Dana Hyunjung Ahn, Je-Sung Moon, Hyun-Jung Han, Kieun Bae & Kyong-Ah Yoon. (2021) Longitudinal assessment of B-RAF V595E levels in the peripheral cell-free tumor DNA of a 10-year-old spayed female Korean Jindo dog with unresectable metastatic urethral transitional cell carcinoma for monitoring the treatment response to a RAF inhibitor (sorafenib). Veterinary Quarterly 41:1, pages 153-162.
Read now
Read now
Hee Man Kim, Sun A Kim, Soo Been Park, Jae Hee Cho & Si Young Song. (2017) Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth. Scandinavian Journal of Gastroenterology 52:5, pages 577-584.
Read now
Read now
Sarah E. Fenton, Jeffrey A. Sosman & Sunandana Chandra. (2017) Emerging growth factor receptor antagonists for the treatment of advanced melanoma. Expert Opinion on Emerging Drugs 22:2, pages 165-174.
Read now
Read now
Massimo Gentile, Massimo Martino, Anna Grazia Recchia, Ernesto Vigna, Lucio Morabito & Fortunato Morabito. (2016) Sorafenib for the treatment of multiple myeloma. Expert Opinion on Investigational Drugs 25:6, pages 743-749.
Read now
Read now
Karissa M Johnston, Emily McPherson, Katherine Osenenko, Joanna Vergidis, Adrian R Levy & Stuart Peacock. (2015) Cost–effectiveness of therapies for melanoma. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 229-242.
Read now
Read now
Mirjana Urosevic-Maiwald, Marjam J Barysch, Phil F Cheng, Maria B Karpova, Hans Steinert, Michal J Okoniewski & Reinhard Dummer. (2015) In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma. OncoImmunology 4:2.
Read now
Read now
Umberto Leone Roberti Maggiore, Mario Valenzano Menada, Pier Luigi Venturini & Simone Ferrero. (2013)
Sorafenib for ovarian cancer. Expert Opinion on Investigational Drugs 22:8, pages 1049-1062.
Read now
Read now
Malgorzata Mackiewicz-Wysocka, Jakub Zolnierek & Piotr J Wysocki. (2013) New therapeutic options in systemic treatment of advanced cutaneous melanoma. Expert Opinion on Investigational Drugs 22:2, pages 181-190.
Read now
Read now
Diwakar Davar & John Munn Kirkwood. (2012) New therapies in the treatment of melanoma. Expert Opinion on Investigational Drugs 21:11, pages 1643-1659.
Read now
Read now
Articles from other publishers (29)
Alison Celine Dcruz, Vignesh Balaji E, Suman Manandhar, Akshara Kumar, Tanvi V. Gujaran, Paniz Hedayat & K. Sreedhara Ranganath Pai. (2023) BRAF gene as a potential target to attenuate drug resistance and treat cancer. Gene Reports 30, pages 101740.
Crossref
Crossref
Abdalla R. Mohamed & Ahmed M. El Kerdawy. (2022) A Perspective Study on the RTK, PI3K, B‐Raf, CDK and the Multi‐Protein Targeting in Medicinal Chemistry. Chemistry & Biodiversity 19:10.
Crossref
Crossref
Hongyu Kong, Rong Zhang, Qinghe Jing, Yu Liang, Qiao Zhuo, Bo Li, Shujie Zhang, Weiliang Zhu & Chen Zhao. (2022) Intravitreal injection of EV11, a novel aryl ketone amide, inhibits choroidal neovascularization via AKT/ERK1/2 pathway. Microvascular Research 143, pages 104401.
Crossref
Crossref
Francesca Laneri, Adriana C. E. Graziano, Mimimorena Seggio, Aurore Fraix, Milo Malanga, Szabolcs Béni, Giuseppe Longobardi, Claudia Conte, Fabiana Quaglia & Salvatore Sortino. (2022) Enhancing the Anticancer Activity of Sorafenib through Its Combination with a Nitric Oxide Photodelivering β-Cyclodextrin Polymer. Molecules 27:6, pages 1918.
Crossref
Crossref
Haoxue Zhang, Yuyao Liu, Delin Hu & Shengxiu Liu. (2022) Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma. Frontiers in Oncology 12.
Crossref
Crossref
Sarbjit Singh, Divya Utreja & Vimal Kumar. (2021) Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy. Medicinal Chemistry Research 31:1, pages 1-25.
Crossref
Crossref
A.G. Nerkar. (2021) Metastatic melanomas: Treatment overview. Current Trends in Pharmacy and Pharmaceutical Chemistry 3:4, pages 50-55.
Crossref
Crossref
Angela Bonaccorso, Veronica Pepe, Cristina Zappulla, Cinzia Cimino, Angelo Pricoco, Giovanni Puglisi, Francesco Giuliano, Rosario Pignatello & Claudia Carbone. (2021) Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study. Pharmaceutics 13:11, pages 1956.
Crossref
Crossref
Arkadiusz Z. Dudek, Kate Baxstrom, Sushma Bharadwaj, Anne Blaes, Amit Kulkarni, Emil Lou, Vijeyaluxmy Nehru, Emma Rabinovich, Ardaman Shergill & Maya Viner. 2020. Precision Medicine in Oncology. Precision Medicine in Oncology
1
60
.
Lucie Heinzerling, Anke Hartmann & Martina HundLucie Heinzerling, Anke Hartmann & Martina Hund. 2019. Medikamentöse Tumortherapie in der Dermato-Onkologie. Medikamentöse Tumortherapie in der Dermato-Onkologie
45
134
.
Andreia V. Pinho, Jenny H. Lee & Helen Rizos. 2019. Current Applications for Overcoming Resistance to Targeted Therapies. Current Applications for Overcoming Resistance to Targeted Therapies
223
258
.
Alice Y. Zhou & Douglas B. Johnson. (2017) Combinatorial Therapies in Melanoma: MAPK Inhibitors and Beyond. American Journal of Clinical Dermatology 19:2, pages 181-193.
Crossref
Crossref
Catherine Ropert & Hugo W. Huth. 2017. Molecular Oncology: Underlying Mechanisms and Translational Advancements. Molecular Oncology: Underlying Mechanisms and Translational Advancements
67
91
.
Philip A. Harris. 2018. Cancer II. Cancer II
105
139
.
S. Thurneysen, P.F. Cheng, H.W. Nagel, M. Kunz, N. Jaberg-Bentele, M. Nägeli, M. Ziegler, E. Guenova, S.M. Goldinger, J. Mangana, M.P. Levesque & R. Dummer. (2016) An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel. British Journal of Dermatology 175:5, pages 966-978.
Crossref
Crossref
Nicole R. Dominiak, Mark R. Wick & M. Timothy Smith. (2016) Mucosal melanomas: Site-specific information, comparisons with cutaneous tumors, and differential diagnosis. Seminars in Diagnostic Pathology 33:4, pages 191-197.
Crossref
Crossref
Isabella C. Glitza, Dae Won Kim, Young Kwang Chae & Kevin B. Kim. 2016. Genetics of Melanoma. Genetics of Melanoma
237
265
.
J. S. Fowles, C. L. Denton & D. L. Gustafson. (2015) Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma. Veterinary and Comparative Oncology 13:3, pages 288-304.
Crossref
Crossref
John G. Moffat, Joachim Rudolph & David Bailey. (2014) Phenotypic screening in cancer drug discovery — past, present and future. Nature Reviews Drug Discovery 13:8, pages 588-602.
Crossref
Crossref
Jia-Hui Chu, Cui-Rong Zhao, Zhi-Yu Song, Rui-Qi Wang, Yi-Zhuo Qin, Wen-Bao Li & Xian-Jun Qu. (2014) 1082-39, an analogue of sorafenib, inhibited human cancer cell growth more potently than sorafenib. Biomedicine & Pharmacotherapy 68:3, pages 335-341.
Crossref
Crossref
Abraham Amsterdam, Calanit Raanan, Nava Polin, Ehud Melzer, David Givol & Letizia Schreiber. (2014) Modulation of c-kit expression in pancreatic adenocarcinoma: A novel stem cell marker responsible for the progression of the disease. Acta Histochemica 116:1, pages 197-203.
Crossref
Crossref
Lucie Heinzerling, Anke Hartmann, Martina Hund & Gerold SchulerLucie Heinzerling, Anke Hartmann, Martina Hund & Gerold Schuler. 2014. Medikamentöse Tumortherapie in der Dermato-Onkologie. Medikamentöse Tumortherapie in der Dermato-Onkologie
31
97
.
Michalis Alevizakos, Serafim Kaltsas & Konstantinos N. Syrigos. (2013) The VEGF pathway in lung cancer. Cancer Chemotherapy and Pharmacology 72:6, pages 1169-1181.
Crossref
Crossref
Antonino Mazzaglia, Maria Luisa Bondì, Angela Scala, Francesca Zito, Giovanna Barbieri, Francesco Crea, Giuseppina Vianelli, Placido Mineo, Tiziana Fiore, Claudia Pellerito, Lorenzo Pellerito & Maria Assunta Costa. (2013)
Supramolecular Assemblies Based on Complexes of Nonionic Amphiphilic Cyclodextrins and a
meso
-Tetra(4-sulfonatophenyl)porphine Tributyltin(IV) Derivative: Potential Nanotherapeutics against Melanoma
. Biomacromolecules 14:11, pages 3820-3829.
Crossref
Crossref
Francesca Pretto & Dario Neri. (2013) Pharmacotherapy of metastatic melanoma: Emerging trends and opportunities for a cure. Pharmacology & Therapeutics 139:3, pages 405-411.
Crossref
Crossref
Victoria K. Hill, Jared J. Gartner, Yardena SamuelsAlisa M. Goldstein. (2013) The Genetics of Melanoma: Recent Advances. Annual Review of Genomics and Human Genetics 14:1, pages 257-279.
Crossref
Crossref
Snezana Djordjevic & Paul C. Driscoll. (2013) Targeting VEGF signalling via the neuropilin co-receptor. Drug Discovery Today 18:9-10, pages 447-455.
Crossref
Crossref
David Chandler & Anthony Bewley. (2013) Biologics in Dermatology. Pharmaceuticals 6:4, pages 557-578.
Crossref
Crossref
Alyson K. Freeman & Deborah K. Morrison. 2013. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy
47
67
.